KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:TYME
Delisted

Tyme Technologies Inc Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.311
+0 (+0%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Nov 14, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 11, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 10, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 09, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 08, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 07, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 04, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 03, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 02, 2022 $0.311 $0.311 $0.311 $0.311 0
Nov 01, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 31, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 28, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 27, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 26, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 25, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 24, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 21, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 20, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 19, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 18, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 17, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 14, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 13, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 12, 2022 $0.311 $0.311 $0.311 $0.311 0
Oct 11, 2022 $0.311 $0.311 $0.311 $0.311 0
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT